Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	39.07	33.9	28.04	43.07	59.71	54.95
Short-Term Investments	241.63	337.18	454.88	394.3	280.17	283.55
Cash & Short-Term Investments	280.7	371.08	482.92	437.37	339.89	338.51
Cash Growth	-28.26%	-23.16%	10.41%	28.68%	0.41%	403.38%
Accounts Receivable	-	5	-	-	-	0.42
Other Current Assets	7.61	9.98	13.8	14.56	10.88	6.18
Total Current Assets	288.3	386.07	496.72	451.93	350.77	345.1
Net Property, Plant & Equipment	33.12	37.23	41.74	50.08	52.84	3.62
Other Intangible Assets	-	-	-	-	-	8.8
Goodwill	-	-	3.74	3.74	3.74	3.74
Long-Term Investments	-	-	-	21.21	37.5	-
Other Long-Term Assets	5.83	7.04	9.5	12.35	9.67	4.3
Total Assets	327.25	430.34	551.69	539.31	454.51	365.56
Accounts Payable	7.03	7.44	14.93	11.25	11.59	8.66
Accrued Expenses	30.14	45.29	54.44	45.4	32.35	19.94
Total Current Liabilities	37.17	52.73	69.37	56.65	43.94	28.6
Long-Term Leases	36.71	39.58	43.15	45.17	44.46	1.1
Other Long-Term Liabilities	0.5	0.85	1.78	3.47	1.62	2.48
Total Long-Term Liabilities	37.21	40.43	44.93	48.64	46.08	3.58
Total Liabilities	74.38	93.15	114.3	105.29	90.03	32.18
Common Stock	0.07	0.07	0.07	0.06	0.05	0.04
Additional Paid-in Capital	1,409	1,391	1,324	1,031	723.59	509.34
Accumulated Other Comprehensive Income	0.19	0.56	2.19	-1.35	-0.13	0.04
Retained Earnings	-1,156	-1,054	-888.56	-596.37	-359.56	-200.83
Total Common Shareholders' Equity	252.87	337.19	437.28	433.8	363.95	308.58
Minority Interest	-	-	0.11	0.22	0.53	24.8
Shareholders' Equity	252.87	337.19	437.39	434.02	364.48	333.38
Total Liabilities & Equity	327.25	430.34	551.69	539.31	454.51	365.56
Total Debt	36.71	39.58	43.15	45.17	44.46	1.1
Net Cash (Debt)	243.99	331.51	439.77	392.21	295.43	337.41
Net Cash Growth	-26.40%	-24.62%	12.13%	32.76%	-12.44%	401.75%
Net Cash Per Share	3.40	4.66	6.72	7.42	6.92	12.00
Book Value	252.87	337.19	437.28	433.8	363.95	308.58
Book Value Per Share	3.52	4.74	6.69	8.21	8.53	10.98
Tangible Book Value	252.87	337.19	433.55	430.07	360.22	296.05
Tangible Book Value Per Share	3.52	4.74	6.63	8.14	8.44	10.53

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q